In addition, we showed that TRIM44 overexpression leads to high mTOR activity, a finding supported by the reduced mTOR signaling in cancer cell lines after siRNA knockdown of TRIM44, and colocalization of TRIM44 with p-mTOR in patient samples [13]. This evidence concerns the gene MTOR and cancer.